PRIMARY STUDY
Enhancement of Anandamide-Mediated Endocannabinoid Signaling Corrects Autism-Related Social Impairment
Key Findings: This mouse study of behavioral changes in a model of autism spectrum disorder (ASD) found that increased levels of anandamide via CB1 receptors improved social impairments and may present a future therapeutic target in the treatment of ASD by inhibiting fatty acid amide hydrolase (FAAH).
Type of Study: Animal Study
Study Result: Positive
Study Location(s): China, Italy, United States
Year of Pub: 2016
Cannabinoids Studied: AM-x Synthetic Cannabinoids, Anandamide (AEA), Fatty Acid Amide Hydrolase (FAAH)
Phytocannabinoid Source: Not Applicable
Receptors Studied: CB1
